Oligodendroglial tumor chemotherapy using “decreased-dose-intensity” PCV: A Singapore experience

@article{Ty2006OligodendroglialTC,
  title={Oligodendroglial tumor chemotherapy using “decreased-dose-intensity” PCV: A Singapore experience},
  author={A. Ty and S. See and J. P. Rao and J. Khoo and M. C. Wong},
  journal={Neurology},
  year={2006},
  volume={66},
  pages={247 - 249}
}
The authors propose “decreased-dose-intensity” PCV (procarbazine, lomustine [CCNU], and vincristine) chemotherapy for Asian patients with oligodendroglial tumors. In this study, all seven patients with oligodendroglioma (OD) and eight with anaplastic oligodendroglioma (AO) had objective responses or stable disease. Median progression-free survival was greater than 29 months (OD) and 36.5 months or greater (AO); 86% of patients with OD and 63% with AO remain progression-free. Twenty-four Common… Expand
9 Citations
Chemotherapy for diffuse low-grade gliomas in adults.
  • 5
Chemotherapy in low-grade gliomas
  • 18
Proteomics and Biomarkers Based Diagnosis of Brain Tumor: A Review

References

SHOWING 1-10 OF 15 REFERENCES
Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group.
  • 418
Effects of ACNU and radiotherapy on malignant glioma.
  • 180
Cerebrovascular complications of Fabry's disease
  • 281
...
1
2
...